ALMBIH — Evidencija nestasice lijekova (Bosnia & Herzegovina) (ALMBIH)
ALMBIH — Evidencija nestasice lijekova (Bosnia & Herzegovina) is the official source of medicine shortage information for Bosnia and Herzegovina (Europe). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- lijekovi.almbih.gov.ba
- Country
- Bosnia and Herzegovina
- Notices tracked by Mederti
- 173
- Last checked
- 31 Oct 2026
Latest notices from ALMBIH
- Promazin — active, medium, since 27 Oct 2026 (source)
- Nimesulide — active, medium, since 27 Oct 2026 (source)
- Finasterida Stada — active, medium, since 27 Oct 2026 (source)
- Askorbinska Kiselina, Paracetamol — active, medium, since 23 Oct 2026 (source)
- Enalapril — active, medium, since 22 Oct 2026 (source)
- Enalapril — active, medium, since 19 Oct 2026 (source)
- Askorbinska Kiselina, Paracetamol — active, medium, since 15 Oct 2026 (source)
- Pazopanib — active, medium, since 15 Oct 2026 (source)
- Budesonid — active, medium, since 8 Oct 2026 (source)
- Azelastina Abamed — active, medium, since 8 Oct 2026 (source)
- Dobutamine (Chlorhydrate De) — active, medium, since 5 Oct 2026 (source)
- Betahistina Normon — active, medium, since 21 Sept 2026 (source)
- Levetiracetam — active, medium, since 21 Sept 2026 (source)
- Pregabalin — active, medium, since 18 Sept 2026 (source)
- Mebeverine-Hydrochloride — active, medium, since 18 Sept 2026 (source)
Every ALMBIH notice, searchable and alertable
Search Bosnia and Herzegovina's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by ALMBIH — Evidencija nestasice lijekova (Bosnia & Herzegovina). All notices remain the property of their publisher and are linked to the original source.